You have 9 free searches left this month | for more free features.

Ursodeoxycholic Acid

Showing 1 - 25 of 8,001

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Liver Regeneration, Ursodeoxycholic Acid, Partial Liver Resection Trial in New Delhi (Ursodeoxycholic acid, Standard Medical

Not yet recruiting
  • Liver Regeneration
  • +2 more
  • Ursodeoxycholic acid
  • Standard Medical Treatment
  • New Delhi, India
    Institute of Liver and Biliary Sciences
Oct 18, 2023

Rheumatoid Arthritis Trial in Shibin Al Kawm (Placebo, Ursodeoxycholic acid (UDCA) 500 mg)

Recruiting
  • Rheumatoid Arthritis
  • Placebo
  • Ursodeoxycholic acid (UDCA) 500 mg
  • Shibīn Al Kawm, Egypt
    Menoufia University Hospital
Aug 1, 2023

Gestational Diabetes Trial in Murcia (500 mg of ursodeoxycholic acid (UDCA), 500 mg of Placebo)

Completed
  • Gestational Diabetes
  • 500 mg of ursodeoxycholic acid (UDCA)
  • 500 mg of Placebo
  • Murcia, Spain
    Hospital Clínico Universitario Virgen de la Arrixaca
Nov 10, 2023

Primary Biliary Cholangitis Trial in Xi'an (Placebo Combined With Ursodeoxycholic Acid, Fenofibrate Combined With

Recruiting
  • Primary Biliary Cholangitis
  • Placebo Combined With Ursodeoxycholic Acid
  • Fenofibrate Combined With Ursodeoxycholic Acid
  • Xi'an, Shaanxi, China
    Ying han
Mar 3, 2023

COVID-19 Trial (Ursodeoxycholic acid)

Not yet recruiting
  • COVID-19
  • Ursodeoxycholic acid
  • (no location specified)
Dec 20, 2022

Cardiac Surgery Trial in Beijing (Nirmatrelvir/ritonavir, Ursodeoxycholic acid)

Recruiting
  • Cardiac Surgery
  • Beijing, Beijing, China
    Fuwai Hospital
Jan 18, 2023

Diabetes, Type 2 Trial in Tanta, Shibin Al Kawm (Ursodeoxycholic acid)

Recruiting
  • Diabetes Mellitus, Type 2
  • Ursodeoxycholic acid
  • Tanta, El-Gharbia, Egypt
  • +1 more
Jun 5, 2023

Ursodeoxycholic Acid on Preventing Covid-19 Infection in Organ

Completed
  • Organ Transplantation
  • COVID-19
  • Medication history
  • (no location specified)
Jan 12, 2023

Gestational Diabetes Trial in London (Metformin, Ursodeoxycholic Acid)

Recruiting
  • Gestational Diabetes
  • London, United Kingdom
    Guy's and St Thomas' NHS Foundation Trust
Aug 17, 2022

Primary Biliary Cholangitis Trial in Xi'an (Fenofibrate 200mg, Placebo, UDCA)

Recruiting
  • Primary Biliary Cholangitis
  • Fenofibrate 200mg
  • +2 more
  • Xi'an, Shaanxi, China
    Xijing Hospital
Mar 3, 2023

Diabetes, Type 2 Trial in Banja Luka (UDCA (Ursodeoxycholic acid), Placebo, Metformin)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • UDCA (Ursodeoxycholic acid)
  • +2 more
  • Banja Luka, Republic Of Srpska, Bosnia and Herzegovina
    Public Health Institution Dom zdravlja Banja Luka
Jun 8, 2022

Primary Biliary Cholangitis Trial in United States (Seladelpar 10 mg, Placebo)

Recruiting
  • Primary Biliary Cholangitis
  • Seladelpar 10 mg
  • Placebo
  • Chandler, Arizona
  • +3 more
Oct 2, 2023

Rheumatoid Arthritis Trial in Shibin Al Kawm (Placebo, Digoxin 0.25 mg, Ursodeoxycholic acid (UDCA) 500 mg)

Recruiting
  • Rheumatoid Arthritis
  • Placebo
  • +2 more
  • Shibīn Al Kawm, Egypt
    Menoufia University Hospital
Apr 5, 2022

Primary Biliary Cholangitis Trial in Beijing (ursodeoxycholic acid)

Recruiting
  • Primary Biliary Cholangitis
  • ursodeoxycholic acid
  • Beijing, China
    Peking Union Medical College Hospital
Apr 28, 2022

Healthy Subject Trial in Seoul (Ursodeoxycholic Acid 250 Mg Oral Tablet)

Completed
  • Healthy Subject
  • Ursodeoxycholic Acid 250 Mg Oral Tablet
  • Seoul, Korea, Republic Of, Korea, Democratic People's Republic of
    Kyung Hee University Medical Hospital
Apr 16, 2023

Gastric Cancer Trial in Seoul (Patients who continued UDCA 300mg medication, Patients who discontinued UDCA 300mg prescription)

Recruiting
  • Gastric Cancer
  • Patients who continued UDCA 300mg medication
  • Patients who discontinued UDCA 300mg prescription
  • Seoul, Korea, Republic of
    DoJoong Park
Jun 6, 2022

Hepatitis, Autoimmune, Cholangitis, Liver Cirrhosis, Biliary Trial in Chengdu (Ursodeoxycholic acid combination of

Recruiting
  • Hepatitis, Autoimmune
  • +3 more
  • Ursodeoxycholic acid combination of immunosuppressive agents
  • Ursodeoxycholic Acid
  • Chengdu, Sichuan, China
    West China Hospital
Oct 26, 2021

COVID-19 Infection and Its Clinical Prognosis in Autoimmune

Recruiting
  • COVID-19 Infection
  • ursodeoxycholic acid
  • Beijing, Beijing, China
    Department of Hepatology Division 2, Beijing Ditan Hospital
Apr 11, 2023

Diabetes Trial in Xi'an (UDCA)

Recruiting
  • Diabetes Mellitus
  • Xi'an, Shanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Aug 11, 2022

Hepatitis D Trial in Taipei (Ursodeoxycholic acid, Ropeginterferon alfa-2b, Tenofovir Alafenamide)

Not yet recruiting
  • Hepatitis D
  • Ursodeoxycholic acid
  • +2 more
  • Taipei, Taiwan
  • +1 more
Jul 19, 2022

Biliary Atresia, Cholangitis, Anti-Bacterial Agents Trial (Basic treatment: sulperazone + ursodeoxycholic acid + compound

Not yet recruiting
  • Biliary Atresia
  • +2 more
  • Basic treatment: sulperazone + ursodeoxycholic acid + compound glycyrrhizin + methylprednisolone + vitamin AD , D , E , K + imipenem or meropenem
  • Prophylactic oral antibiotics: compound sulfamethoxazole tablet (SMZ/TMP) + cefaclor
  • (no location specified)
Jun 28, 2023

sCD163 in PBC Patients - Assessment of Treatment Response

Recruiting
  • Primary Biliary Cirrhosis
  • +2 more
  • Blood samples
  • +3 more
  • Aarhus C, Region Midtjylland, Denmark
    Department of Hepatology and Gastroenterology, Aarhus University
Aug 11, 2022

Chinese Primary Biliary Cholangitis on Ursodeoxycholic Acid

Recruiting
  • Primary Biliary Cholangitis (PBC)
  • Ursodeoxycholic Acid
  • Beijing, China
    Centre of non-infectious liver diseases, Beijing 302 Hospital, B
Aug 27, 2021

Polycystic Liver Disease, Polycystic Kidney, Autosomal Dominant Trial in Nijmegen, Amsterdam, San Sebastian (Ursodeoxycholic

Completed
  • Polycystic Liver Disease
  • Polycystic Kidney, Autosomal Dominant
  • Ursodeoxycholic Acid
  • Nijmegen, Gelderland, Netherlands
  • +2 more
Sep 16, 2021

Bone Regeneration Trial in Hyderabad (Ursodeoxycholic acid gel)

Recruiting
  • Bone Regeneration
  • Ursodeoxycholic acid gel
  • Hyderabad, Telangana, India
    SVS Institute of Dental Sciences
Jun 17, 2021